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The use of Antimicrobial Photodynamic Therapy (APDT) as a new approach to treat localized Candida
infections is an emerging and promising ﬁeld nowadays. The aim of this study was to verify the efﬁcacy
of photodynamic therapy using two new benzo[a]phenoxazinium photosensitizers against Candida
albicans bioﬁlms: N-(5-(3-hydroxypropylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene)ethana-
minium chloride (FSc) and N-(5-(11-hydroxyundecylamino)-10-methyl-9H-benzo[a]phenoxazin-9-yli-
dene)ethanaminium chloride (FSd). The photodynamic activity of dyes against C. albicans bioﬁlms was
evaluated by incubating bioﬁlms with dyes in the range of 100–300 lM for 3 or 18 h followed by illumi-
nation at 12 or 36 J cm2, using a xenon arc lamp (600 ± 2 nm). A total photoinactivation of C. albicans
bioﬁlm cells was achieved using 300 lM of FSc with 18 h of incubation, followed by illumination at
36 J cm2. Contrarily, FSd had insigniﬁcant effect on bioﬁlms inactivation by APDT. The higher uptake
of FSc than FSd dye by bioﬁlms during the dark incubation may explain the greater photodynamic effec-
tiveness achieved with FSc. The results obtained stresses out the FSc-mediated APDT potential use to
treat C. albicans infections.
 2014 Elsevier B.V. All rights reserved.1. Introduction
In the last decades, the incidence of superﬁcial and systemic
fungal infections has increased due to several factors, including
the more frequent use of invasive procedures, prosthetic devices,
immunosupressive medication and broad-spectrum antibiotics,
as well as the increased incidence of neutropenia and HIV infec-
tions [1]. Candida albicans is the most virulent Candida species
and represents an important public health challenge with a high
economic and medical relevance due to the increased costs of care,
time of hospitalization and high morbidity and mortality rates,
especially on immunocompromised patients [2]. The pathogenicity
of C. albicansmay be attributed to several virulence factors, includ-
ing production of some tissue-damaging hydrolytic enzymes, as
well as adherence and bioﬁlm formation on host tissues and med-
ical devices (e.g. catheters and prosthetic devices) [2]. Bioﬁlm for-
mation is one of the main virulence factors of C. albicans, because
these communities show different phenotype characteristics thantheir planktonic counterparts, particularly increased resistance to
antimicrobial agents [3,4]. The clinical signiﬁcance of bioﬁlms is
highlighted by recent estimates that over 65% of all hospital infec-
tions are originated by these microbial communities [5,6]. The use
of conventional antifungal treatments can be prolonged, expensive
and has been more and more associated with the appearance of
resistant strains in the last few years. For this reason, there is an
increased need of more effective and localized antifungal thera-
peutic options to treat fungal infections [7]. Photodynamic therapy,
originally developed for the treatment of skin tumors, has been
shown as an effective therapy to eliminate bacteria and fungi that
cause localized infections of the skin and oral cavity [8–21]. Anti-
microbial Photodynamic Therapy (APDT) combines a non-toxic
and light sensitive dye, termed photosensitizer, with oxygen and
harmless visible light with appropriate wavelength. Upon illumi-
nation, the photosensitizer is excited and can undergo reaction
with ambient oxygen resulting in the formation of Reactive Oxygen
Species (ROS), leading to oxidative stress that can cause growth
inhibition and cell death [22]. As photosensitizers may cross the
plasma membrane and take different subcellular localizations, sev-
eral intracellular components may be affected during the oxidative
stress caused by ROS produced, affecting the cell functions and its
Fig. 1. Structures of benzo[a]phenoxazinium chlorides FSc and FSd.
Table 1
Photophysical properties of dyes in ethanol, DMSO and PBS, namely, wavelength of
maximum absorption (kmax), excitation wavelength (kex), emission wavelength (kem)
and relative ﬂuorescence quantum yield (UF).
Dye Solvent kmax (nm) kem (nm) UF
FSc Ethanol 628 646 0.41
DMSO 631
PBS 618/579
FSd Ethanol 631 654 0.29
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include plasma membrane, mitochondria, vacuoles, Golgi appara-
tus and endoplasmic reticulum [23]. The main ROS produced upon
light excitation is the termed singlet oxygen (1O2), a form of oxy-
gen that is very short lived, extremely reactive and has a very lim-
ited diffusivity (in a radius of approximately 20 nm) [22]. For these
reasons this therapy can have a simultaneous localized effect,
where only molecules and structures within the microenviron-
ment of the photosensitizer are affected by singlet oxygen
[22,23]. Thus, sterilization of oral cavities and root canals, as well
as treatment of localized infections seems to be the main promis-
ing applications of APDT [20,21,24,25].
Several forms of photosensitizers have been created during the
last few years, particularly dyes belonging to the class of porphy-
rins, phthalocyanines and phenothiazines [7,25,26]. Cationic
photosensitizers with an absorption peak wavelength in the far
red (600–800 nm) seem to be the more effective structures to kill
both bacteria and fungi [7,22,25]. Accordingly to Foley et al. [27],
some benzo[a]phenoxazinium chalcogen analogues can have great
photoinduced activity against yeasts and bacteria, such as C. albi-
cans, Escherichia coli and Enterococcus faecalis [26]. In this context,
the main objective of the present work was to investigate the
potential antifungal photodynamic activity using two new
benzo[a]phenoxazinium chlorides against C. albicans bioﬁlms.DMSO 639
PBS 6152. Materials and methods
2.1. Organisms and growth conditions
The strain C. albicans ATCC 90028, was preserved at 80 C in a
storage solution of Sabouraud Dextrose Broth (SDB; Lioﬁlchem,
Roseto degli Abruzzi, Italy) supplemented with 20% glycerol. Prior
to each experiment, yeast cells were sub-cultured on Sabouraud
Dextrose Agar (SDA; Lioﬁlchem, Roseto degli Abruzzi, Italy) for
48 h at 37 C. Then, one loopful of single-cell colonies (3–5 colonies)
was inoculated in 30 ml of SDB and incubated for 18 h, at 37 C,
under constant agitation at 120 rev/min. After this step, cells were
harvested by centrifugation at 3000g for 10 min at 4 C and washed
twicewith 15 ml of Phosphate Buffer Solution (PBS – pH 7.5; 0.1 M).
The pellets were then suspended in 10 ml of SDB and the cellular
density was adjusted to 1  107 cells ml1 using an improved Neu-
bauer haemocytometer (Marienﬁld, Land-Könicshofen, Germany).
Bioﬁlms were grown at 37 C under agitation at 120 rev/min for
48 h, in a 96-wells polystyrene microtiter plates (Orange Scientiﬁc,
Braine-l’Alleud, Belgium), with the reposition of 100 ll of fresh
medium after 24 h. In each plate, an interval of three wells between
each well was used to avoid side light exposure during bioﬁlms
photoinactivation. After bioﬁlm formation the medium was aspi-
rated and non-adherent cells removed by washing bioﬁlms once
with PBS.Fig. 2. Absorption spectra of compounds FSc and FSd in ethanol (EtOH), PBS and
DMSO.2.2. Photosensitizers
The benzo[a]phenoxazinium chlorides termed N-(5-(3-
hydroxypropylamino)-10-methyl-9H-benzo[a]phenoxazin-9-yli-
dene)ethanaminium chloride – FSc and N-(5-(11-hydroxyunde-
cylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene)ethana-
minium chloride – FSd (Fig. 1) were previously synthetized in the
Department of Chemistry of University of Minho [28,29] and the
respective powders were solubilized in Dimethyl Sulfoxide
(DMSO) to a ﬁnal concentration of 10 mM. Then, the solutions
were transferred to sterile amber microtubes (VWR International,
LLC. USA) to avoid ambient light and were stored at 4 C. Immedi-
ately before each experiment, aliquots of the dyes were diluted in
sterile PBS to obtain working solutions of 100, 200 and 300 lM.Table 1 shows the main photophysical properties of both dyes.
The absorption spectra in ethanol, PBS buffer and DMSO are shown
in Fig. 2. The compound with a longer alkyl chain (FSd) is slightly
red-shifted showing a higher fraction of a band near 500 nm, that
corresponds to the neutral basic form [28,29]. Also, as expected,
compound FSd has much less solubility in PBS aqueous buffer. In
bioﬁlm compound FSd is probably in a less hydrated environment
than compound FSc. Considering the higher tendency of FSd to
deprotonate, the absorption at the irradiation wavelength is
expected to be lower than for FSc.
2.3. Photodynamic inactivation
After the bioﬁlms were formed, dyes (200 ll) were added to
bioﬁlms and the plates were incubated in the dark during 3 or
18 h at 37 C under agitation (120 rev/min). Dyes were then
aspired and bioﬁlms were washed twice with PBS to remove
loosely attached cells and excess of dye. After, 200 ll of PBS were
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Bunsen burner) illuminated at an average irradiance of
10 mW cm2 with a xenon arc lamp (OSRAM HBO 200W) equipped
with a bandpass ﬁlter centered on 600 ± 2 nm (ThorLabs, New Jer-
sey, USA). Bioﬁlms were illuminated for 20 or 60 min, correspond-
ing to a ﬂuence of 12 J cm2 and 36 J cm2, respectively. Exact
power was measured at the end of every experiment with an inte-
grating sphere photodiode power sensor (model S144C; ThorLabs,
New Jersey, USA) using the PM100D Utility software (Thorlabs;
New Jersey, USA). The number of cultivable bioﬁlm cells was then
determined by colony forming units (CFU) after bioﬁlm cells resus-
pension. In a detailed way, the bioﬁlms were ﬁrstly resuspended in
200 ll of PBS by scraping the adhered biomass from the wells
using a tip and repeated pipetting. Then, these 200 ll were col-
lected to a sterile microtube and the same method was done with
100 ll of PBS to guarantee that each bioﬁlm cell was totally resus-
pended. The resulting bioﬁlm cells of each 2 wells per condition
were collected to the same microtube to form a single cell suspen-
sion and vigorously vortexed during 1 min to disrupt the bioﬁlm
matrix. Then, serial decimal dilutions in PBS were done and plated
onto SDA. Agar plates were incubated at 37 C for 24 h and the total
CFUs per unit area (Log CFU cm2) of plate well was enumerated.
Light controls (bioﬁlms illuminated with PBS only; ﬂu-
ence = 12 J cm2 or 36 J cm2) and dye alone controls (bioﬁlm
incubated with dyes at 100, 200 or 300 lM without light activa-
tion; ﬂuence = 0 J cm2) were also included. Experiments were per-
formed at least in three independent assays with each condition
evaluated in duplicate.
2.4. Dye uptake
After the bioﬁlms were formed, bioﬁlms were incubated in the
dark with both dyes at the concentration of 100 lM and 300 lM
during 3 or 18 h at the same conditions of photodynamic inactiva-
tion assays. After dark incubation, bioﬁlms were washed twice
with PBS and resuspended as described in Section 2.3. The result-
ing resuspended bioﬁlms of each 3 wells per condition were col-
lected to form a single cell suspension and centrifuged at 6654g
for 5 min at 4 C to harvest cells. The supernatants were then col-
lected for ﬂuorescence analysis to measure dye retained by the
extracellular matrix. The pellets were resuspended in 900 ll of
PBS and sonicated (3 cycles of 60 s with 30 s off between each
cycle, at 20 kHz and 35% of power output) using a VCX750 ultra-
sonic processor (Cole-Parmer, USA) to lyse cells and release dye
taken up during the dark incubation. The resulting lysates were
then centrifuged and the supernatants were collected for ﬂuores-
cence analysis to measure dye absorbed by the C. albicans cells.
Sonication parameters were previously optimized in order to pro-
mote the complete lysis of all bioﬁlm cells.
For ﬂuorescence analysis, 200 ll of each supernatant solution
were placed in triplicate on a black 96-wells pureGrade microtiter
plate (VWR, Portugal). Fluorescence was determined through a
microtiter plate reader (Bio-Tek Synergy HT, Izasa, Portugal) with
excitation wavelength set to 590 nm and the emission wavelength
set to 645 nm. Results were expressed as concentration of dye on
supernatant (lM) using previously prepared standard curves of
ﬂuorescence intensity versus concentration of dyes in PBS. All
experiments were performed at least in three independent assays
with each condition evaluated in triplicate. Control wells contain-
ing bioﬁlms only with PBS were also performed.
2.5. Fluorescence microscopy
For ﬂuorescence microscopy analysis, several bioﬁlms were
formed and incubated in the dark with both dyes at the 300 lM
concentration for 3 or 18 h at the same conditions described above.Then, bioﬁlms were washed twice in 200 ll of PBS and resus-
pended in the same volume of PBS. Cells were harvested by centri-
fugation at 1700g for 5 min at room temperature and washed again
twice in 200 ll of PBS. After the last wash, the resulting pellets
were resuspended on 20 ll of PBS, transferred to microscope slides
and examined in a BX51 Olympus Fluorescence Microscope using
the TRITC ﬁlter and the same exposure time. The obtained images
are result of two experiments with a single evaluation of each
condition.
2.6. Statistical analysis
Results were compared using a two-way ANOVA with the Bon-
ferroni post-test using GraphPad Prism 5 software. All tests were
performed with a conﬁdence level of 95%.3. Results
3.1. Photodynamic inactivation
In order to determine the optimal parameters for FSc and FSd-
mediated APDT, three different dyes concentrations and two differ-
ent ﬂuences were evaluated using two different incubation periods
(Fig. 3).
In comparison with the dye alone controls, all APDT conditions
using 12 J cm2 of ﬂuence showed no photodynamic efﬁcacy
against C. albicans bioﬁlms (P > 0.05) when dyes were incubated
for 3 h with bioﬁlms in the dark. It is possible to observe in
Fig. 3-IA and Fig. 3-IB that only a 300 lM concentration of FSc
showed a signiﬁcant decrease (P < 0.05) of viable cells after incuba-
tion with C. albicans bioﬁlms for 3 h in the dark followed by expo-
sure to a ﬂuence of 36 J cm2.
The use of a longer incubation period (18 h) with FSc resulted in
a high photodynamic efﬁcacy against C. albicans bioﬁlms (Fig. 3-
IIA). When compared with the dye alone controls, a signiﬁcant
decrease of viable cells (P < 0.05) of 0.95 log and 1.32 log were
achieved when bioﬁlms were respectively treated with FSc at
200 lM and 300 lM and exposed to 12 J cm2. Moreover, a signif-
icant decrease (P < 0.05) of 1.47 log, 1.77 log and a complete cell
inactivation were observed with FSc concentrations of 100 lM,
200 lM, and 300 lM, respectively, followed by exposure to the
higher ﬂuence. In opposition, FSd showed no photodynamic action
(Fig. 3-IIB), even when all dyes concentrations were combined with
the highest light ﬂuence (36 J cm2). It should be noted that the
lower light ﬂuence (12 J cm2) was not assessed with this photo-
sensitizer due to the absence of effect at higher ﬂuence.
3.2. Dye uptake
The APDT effectiveness of photosensitizers might depend on
their photochemical efﬁciencies, the degree of cell-dye binding,
or both [27]. Therefore, the concentration of dye retained in the
extracellular matrix and absorbed by C. albicans cells after the dark
incubation was assessed with the aim to verify if the observed dif-
ferences in APDT effectiveness could be related with dye uptake
(Table 2).
Results presented in Table 2 showed that FSc dye was generally
more absorbed by both bioﬁlm matrix and C. albicans cells, when
compared to FSd dye. Interestingly, the same results also showed
that FSc uptake by the extracellular matrix and cells occurs in a
concentration-dependent manner on both dark incubation periods
(P < 0.05). As it was expected, there was also a signiﬁcant increase
of the dye absorbed by cells by increasing dark incubation period
from 3 to 18 h, using FSc at 100 lM. Likewise, increasing the dark
incubation period using an initial FSc concentration of 300 lM
Fig. 3. Logarithm of number of C. albicans ATCC 90028 bioﬁlm cells per cm2 after (I) 3 h and (II) 18 h of dark incubation with FSc (A) and FSd (B) at different concentrations in
PBS followed by illumination at 0 J cm2 (D), 12 J cm2 (d) or 36 J cm2 (h). Error bars represent standard deviation. *Statistically different from the control, 0 J cm2
(P < 0.05).
Table 2
Uptake of FSc and FSd by bioﬁlms of C. albicans ATCC 90028 after the dark incubation with dyes at 100 and 300 lM in PBS for 3 h or 18 h. The values are means ± standard
deviations.
Initial concentration of dye (lM) Concentration of dye extracted (lM)
Dye retained on extracellular matrix Dye absorbed by cells
3 h 18 h 3 h 18 h
FSc 100 0.54 ± 0.03 0.89 ± 0.25 1.49 ± 0.43 3.46 ± 0.44*D
300 2.22 ± 0.21D 8.69 ± 1.03*D 3.98 ± 0.54D 13.52 ± 4.90*D
FSd 100 0.48 ± 0.31 1.25 ± 0.21 0.13 ± 0.02 0.70 ± 0.04
300 0.61 ± 0.27 1.61 ± 0.04 0.14 ± 0.03 0.64 ± 0.19
* Statistically different from the same situation at 3 h of dark incubation (P < 0.05).
D Statistically different from FSd in the same conditions (P < 0.05).
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taken up by C. albicans cells but also of the dye retained by the
extracellular matrix. The FSd uptake was very poor and was not
inﬂuenced neither by the initial concentration of dye nor by the
incubation time (P > 0.05).
Fluorescence microscopy analysis of bioﬁlm resuspended cells
after incubation in the dark with both dyes at 300 lMwas also per-
formed to strengthen data presented in Table 2. Fig. 4 shows the
resulting micrographs. Differences in absolute ﬂuorescence quan-
tum yields of dyes should be considered.In accordance with the results presented on Table 2, ﬂuores-
cence microscopy micrographs presented in Fig. 4 showed the dark
incubation of bioﬁlms with FSc resulted in higher cell ﬂuorescence
intensity, suggesting higher levels of dye uptake when bioﬁlms
were treated with FSc. Fig. 4 also demonstrates that increasing
the dark incubation period with FSc did not result in higher levels
of cell ﬂuorescence, as it was expected, but instead resulted in dif-
ferent patterns of dye accumulation, being the penetration of the
photosensitizer notorious not only into the yeast cells, but also into
the hyphae (Fig. 4-IIA).
Fig. 4. Fluorescence microscopy micrographs obtained for C. albicans ATCC 90028 bioﬁlm resuspended cells after (I) 3 h and (II) 18 h of dark incubation with (A) FSc and (B)
FSd dye at 300 lM in PBS.
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The increasing incidence of localized fungal infections combined
with the rise of drug-resistant strains has led to the investigation of
new antifungal approaches. In this context, APDT emerged as a
promising therapeutic option due to the antimicrobial effectiveness
against several microorganisms. The susceptibility of fungal species
to photodynamic action of several photosensitizing dyes and light
with appropriate wavelengths has been receiving increased atten-
tion in the last few years. In 2006, Foley et al. [27] described so
far the ﬁrst benzo[a]phenoxazinium analogue that was highly
effective in APDT against C. albicans – the benzo[a]phenoselenazini-
um dye. The authors achieved a 99% of cell killing when planktonic
cultures of 107 cells ml1 were incubated 10 min with this dye at
20 lM and exposed to 4 J cm2. In this study we explored the pos-
sibility to enhance the photodynamic action of benzo[a]phenoxaz-
inium dyes by improving their speciﬁcity to C. albicans cells through
small functional groups modiﬁcations. As a result, we achieved an
optimal set of APDT parameters with FSc dye that promises a com-
plete inactivation of C. albicans bioﬁlms (Fig. 3-IIA). Other studies
have reported signiﬁcant levels of C. albicans cells inactivation using
APDT and different photosensitizers, however most of them were
developed using only cell suspensions [8–12,15–17,20,21]. The
use of similar APDT conditions to this study that demonstrated a
killing effect on C. albicans bioﬁlms was reported by Dovigo et al.
[30] using a commercial porphyrin termed Photogem at 25 mg l1
and a blue LED light at 37.5 J cm2. Nevertheless, the cell viability
reduction achieved was less than 1 log.The high photodynamic efﬁcacy of FSc against C. albicans bio-
ﬁlms may be explained relating the results presented in Fig. 3
and Table 2, where it is well clear that under conditions where
FSc dye was highly taken up by both extracellular matrix and C.
albicans cells, the illuminated bioﬁlms were signiﬁcantly inacti-
vated. This observation suggests the differences on APDT efﬁcacy
of FSc and FSd are perhaps mostly related with dye uptake, being
the presence of the distinct side chains on both dyes the reason for
this difference. The presence of a longer side chain on FSd dye is
probably hampering its diffusion throughout the extracellular
matrix of bioﬁlms, impairing the cell-dye binding and, conse-
quently, dye uptake. The possible formation of dye aggregates or
the higher afﬁnity of this dye to the extracellular matrix constitu-
ents are both plausible reasons for the poor dye diffusion and its
arrival to cells, leading to a non-existent APDT action. In addition,
the diminished light absorption of FSd in PBS could also contribute
to the insigniﬁcant effect of this compound after irradiation.
According to previous studies, the incubation time is a variable
that could affect the dye uptake and, consequently, yeast inactiva-
tion [31–33]. Jackson et al. [31] and Wilson and Mia [32] described
that APDT of planktonic cultures of C. albicans using Toluidine Blue
O was dependent on incubation time used, as well as Dovigo et al.
[33] reported that inactivating C. albicans bioﬁlms with curcumin-
mediated APDT is markedly increased with the increasing of incu-
bation time. In agreement, the results of this study (Table 2)
showed that the efﬁcacy of FSc-mediated APDT on C. albicans bio-
ﬁlms is dependent on incubation time, with the best APDT out-
comes achieved with 18 h of incubation in the dark. Additionally,
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accompanied by an accumulation of FSc in some cellular targets,
including in hyphae, which points the subcellular localization of
dye as an important factor on the notorious killing effect achieved.
Many forms of oxidative stress may be involved in that loss of cell
viability, including lipids peroxidation, proteins and enzymes inac-
tivation, and/or nucleic acids oxidation, depending on the cells dis-
tricts reached by FSc dye [34,35]. On the other hand, our results
suggest that the dye retained by the extracellular matrix of bio-
ﬁlms seems to have also a crucial role on the photodynamic inac-
tivation of bioﬁlms (Table 2). The resulting ROS produced at these
sites during illumination may have exerted oxidative stress on
matrix polysaccharides, leading to bioﬁlm destruction, or may
have caused damages to the outer cell wall of yeasts accelerating
the APDT killing of bioﬁlm’s population [21,35].
Shortly, the data presented in this manuscript support the idea
that FSc-mediated APDT could be an ideal therapy to treat fungal
infections. Indeed, the notorious susceptibility of C. albicans bio-
ﬁlms to APDT using FSc as photosensitizing agent was an impor-
tant step in the potential use of this novel therapeutic strategy.
Still, given the high clinical relevance of C. albicans bioﬁlms, there
is an important need to provide a deep understanding about the
side effects of this therapy in humans. The potential for topical
application of dyes and light only to affected sites in mucocutane-
ous candidosis makes these infections particularly amenable to
APDT [10]. Obviously, the issue of selectivity will be an important
one, since healthy human tissues can be susceptible to damages of
APDT. At this point, Zeina et al. [36,37] have demonstrated that
APDT using Methylene Blue under conditions that lead to effective
killing of common skin microorganisms, including C. albicans,
cause neither cytotoxicity nor DNA damage to keratinocytes
in vitro, supporting the belief that selectivity for the microorgan-
ism may be possible for mucocutaneous candidosis. So, further
in vitro and vivo investigations using FSc as photosensitizing agent
may be developed in order to investigate the possible use of the
herein reported APDT conditions to treat mucocutaneous candido-
sis without harming the host’s normal tissues.Acknowledgments
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